A WELL KNOWN DRUG USED TO PREVENT MIGRAINES MAY DO SO AT THE RISK OF WEAKENING WOMEN’S BONES.
In an article published in the medical journal “Headache” and written by the departments of neurology, pediatrics, obstetrics and gynecology of the University of Toledo College of Medicine, the researchers stated that the anti-epileptic drug, Topiramate (Topamax) reduced bone mineral density in women who used the drug to treat their migraines. 
It was found that 53% of women, who had used topiramate, were found to have osteopenia, which is bone loss that is not normal but not yet diagnosable as osteoporosis.
The researchers also found a correlation between the degree of bone loss and the amount of time the women were using topiramate.
While prevention of migraine is definitely the preferable way to go for chronic migraine sufferers, other safe and natural choices are available that do not introduce bone loss or other side-effects associated with this drug. For more information please go to www.migrelief.com
The MigreLief collection of supplements was created by Akeso Health Sciences to help migraine sufferers of all ages. AKESO formulates world class dietary supplements that provide nutritional support for the most common health issues that concern people most, such as migraines, headaches, joint health, stress & anxiety, memory, sleeplessness, ADHD, and more. Changing lives is the reasons we wake up every day passionate about the special products we provide to our customers. Helping you to get well and stay well is our bottom line.
Sign up for priority access to coupons, specials, health tips, product announcements and more!